HealthLynked Corp.
HLYK
$2.74
-$0.01-0.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -46.69% | -38.12% | -31.36% | -27.42% | -36.82% |
| Total Other Revenue | -50.00% | -51.88% | -30.15% | -95.29% | -15.01% |
| Total Revenue | -46.73% | -38.29% | -31.35% | -28.51% | -36.61% |
| Cost of Revenue | -61.68% | -57.89% | -48.92% | -39.54% | -36.05% |
| Gross Profit | -19.61% | 3.98% | 8.75% | -4.82% | -37.59% |
| SG&A Expenses | 2.65% | -15.57% | -33.02% | -37.61% | -36.30% |
| Depreciation & Amortization | -50.15% | -55.48% | -63.98% | -69.72% | -52.14% |
| Other Operating Expenses | -49.16% | -45.33% | -37.49% | -32.14% | -31.00% |
| Total Operating Expenses | -31.14% | -36.71% | -40.05% | -38.46% | -35.74% |
| Operating Income | 16.57% | 35.41% | 46.66% | 46.10% | 34.89% |
| Income Before Tax | 19.90% | 33.55% | 46.50% | 38.03% | -13.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.90% | 33.55% | 46.50% | 38.03% | -13.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.90% | 33.55% | 46.50% | 38.03% | -12.91% |
| EBIT | 16.57% | 35.41% | 46.66% | 46.10% | 34.89% |
| EBITDA | 16.19% | 33.95% | 46.13% | 45.60% | 33.88% |
| EPS Basic | 21.13% | 34.03% | 46.84% | 38.79% | -10.86% |
| Normalized Basic EPS | 37.80% | 45.46% | 42.54% | 28.79% | 13.94% |
| EPS Diluted | 21.00% | 45.77% | 55.82% | 48.98% | 13.53% |
| Normalized Diluted EPS | 37.80% | 45.46% | 42.54% | 28.79% | 13.94% |
| Average Basic Shares Outstanding | 2.40% | 1.33% | 0.73% | 1.42% | 2.82% |
| Average Diluted Shares Outstanding | 2.40% | 1.33% | 0.73% | 1.42% | 2.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |